10x Genomics, Inc. — Director's Dealing 2021

Aug 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-08-23

Reporting Person: Hindson Benjamin J. (Director, See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-23	Class A Common Stock	S	337	$161.8475	Disposed	47117	Direct

Footnotes

F1: These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.